LYT-200 is generally safe and well-tolerated as a single agent as well as in combination with standard-of-care venetoclax and hypomethylating agents LYT-200 demonstrates clinical benefit as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback